国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產品名稱 貨號 規格
Recombinant Yersinia pseudotuberculosis serotype O:1b Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP418713YAN
CSB-EP418713YAN
CSB-BP418713YAN
CSB-MP418713YAN
CSB-EP418713YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Chaperone protein DnaJ (dnaJ) CSB-YP418714YAN
CSB-EP418714YAN
CSB-BP418714YAN
CSB-MP418714YAN
CSB-EP418714YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Non-canonical purine NTP phosphatase (YpsIP31758_3483) CSB-YP418715YAN
CSB-EP418715YAN
CSB-BP418715YAN
CSB-MP418715YAN
CSB-EP418715YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Autoinducer 2 import ATP-binding protein LsrA (lsrA), partial CSB-YP418716YAN
CSB-EP418716YAN
CSB-BP418716YAN
CSB-MP418716YAN
CSB-EP418716YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b UPF0306 protein YpsIP31758_3570 (YpsIP31758_3570) CSB-YP418717YAN
CSB-EP418717YAN
CSB-BP418717YAN
CSB-MP418717YAN
CSB-EP418717YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b 50S ribosomal protein L21 (rplU) CSB-YP418718YAN
CSB-EP418718YAN
CSB-BP418718YAN
CSB-MP418718YAN
CSB-EP418718YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b HTH-type transcriptional repressor NsrR (nsrR) CSB-YP418719YAN
CSB-EP418719YAN
CSB-BP418719YAN
CSB-MP418719YAN
CSB-EP418719YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b HTH-type transcriptional activator rhaS (rhaS) CSB-YP418720YAN
CSB-EP418720YAN
CSB-BP418720YAN
CSB-MP418720YAN
CSB-EP418720YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Regulator of sigma D (rsd) CSB-YP418721YAN
CSB-EP418721YAN
CSB-BP418721YAN
CSB-MP418721YAN
CSB-EP418721YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b 50S ribosomal protein L11 (rplK) CSB-YP418722YAN
CSB-EP418722YAN
CSB-BP418722YAN
CSB-MP418722YAN
CSB-EP418722YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Ribosomal RNA small subunit methyltransferase B (rsmB) CSB-YP418723YAN
CSB-EP418723YAN
CSB-BP418723YAN
CSB-MP418723YAN
CSB-EP418723YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b 50S ribosomal protein L30 (rpmD) CSB-YP418724YAN
CSB-EP418724YAN
CSB-BP418724YAN
CSB-MP418724YAN
CSB-EP418724YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b 50S ribosomal protein L24 (rplX) CSB-YP418725YAN
CSB-EP418725YAN
CSB-BP418725YAN
CSB-MP418725YAN
CSB-EP418725YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b 50S ribosomal protein L2 (rplB) CSB-YP418726YAN
CSB-EP418726YAN
CSB-BP418726YAN
CSB-MP418726YAN
CSB-EP418726YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b 30S ribosomal protein S7 (rpsG) CSB-YP418727YAN
CSB-EP418727YAN
CSB-BP418727YAN
CSB-MP418727YAN
CSB-EP418727YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Protein tsgA homolog (tsgA), partial CSB-YP418728YAN
CSB-EP418728YAN
CSB-BP418728YAN
CSB-MP418728YAN
CSB-EP418728YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Phosphoenolpyruvate carboxykinase [ATP] (pckA), partial CSB-YP418729YAN
CSB-EP418729YAN
CSB-BP418729YAN
CSB-MP418729YAN
CSB-EP418729YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Glucose-1-phosphate adenylyltransferase (glgC) CSB-YP418730YAN
CSB-EP418730YAN
CSB-BP418730YAN
CSB-MP418730YAN
CSB-EP418730YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Xylose isomerase (xylA) CSB-YP418731YAN
CSB-EP418731YAN
CSB-BP418731YAN
CSB-MP418731YAN
CSB-EP418731YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Glyoxylate/hydroxypyruvate reductase B (ghrB) CSB-YP418732YAN
CSB-EP418732YAN
CSB-BP418732YAN
CSB-MP418732YAN
CSB-EP418732YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質形式,可以通過多種方式產生大量蛋白質、修改基因序列和制造有用的商業產品。重組蛋白的技術資源在重組蛋白的開發過程中,除了表達系統之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質量的重組蛋白,后續的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據他們開發重組蛋白的經驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產,在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質合成機制來產生由該基因編碼的蛋白質。表達載體可使外源基因在宿主細胞中高效表達,經過多年的發展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質?

根據重組蛋白的不同應用,對其生物活性有不同的要求。但是我們如何確保蛋白質的產生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質有任何疑問,涉及到蛋白質的價格、交貨、質量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>